Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul 137-701, Republic of Korea.
Department of Internal Medicine, Pusan National University, School of Medicine, Busan 614-735, Republic of Korea.
Gastroenterol Res Pract. 2014;2014:253860. doi: 10.1155/2014/253860. Epub 2014 Feb 17.
Background and Aims. Conventional endoscopic submucosal resection (EMR) of carcinoid tumors often involves the resection margin, which necessitates further intervention. Endoscopic submucosal dissection (ESD) is widely accepted for removing carcinoid tumors. We aimed to evaluate the clinical usefulness of ESD with that of EMR for resection of type I gastric carcinoid tumors. Patients and Methods. The study enrolled 62 patients (37 males, 25 females; median age, 50 years; range, 40-68 years) who were treated with EMR or ESD at three hospitals; the study group had 87 type I gastric carcinoid tumors with an estimated size of ≤10 mm. The complete resection rate and the complications associated with these two procedures were analyzed. Results. The overall ESD complete resection rate was higher than that of the EMR rate (94.9% versus 83.3%, P value = 0.174). A statistically lower vertical margin involvement rate was achieved when ESD was performed compared to when EMR was performed (2.6% versus 16.7%, P value = 0.038). The complication rate was not significantly different between the two groups. Conclusions. ESD showed a higher complete resection rate, particularly for the vertical margin, with a similar complication rate. We mildly recommend ESD rather than EMR for removing type I gastric carcinoid tumors.
背景与目的。常规的内镜黏膜下切除术(EMR)切除类癌肿瘤常涉及切除边缘,这需要进一步的干预。内镜黏膜下剥离术(ESD)广泛用于切除类癌肿瘤。我们旨在评估 ESD 与 EMR 切除 I 型胃类癌肿瘤的临床应用价值。
患者和方法。本研究纳入了在三家医院接受 EMR 或 ESD 治疗的 62 名患者(37 名男性,25 名女性;中位年龄为 50 岁;年龄范围为 40-68 岁);研究组有 87 个大小估计≤10mm 的 I 型胃类癌肿瘤。分析了这两种手术的完全切除率和相关并发症。
结果。ESD 的总体完全切除率高于 EMR(94.9%对 83.3%,P 值=0.174)。与 EMR 相比,ESD 时垂直切缘受累的发生率较低(2.6%对 16.7%,P 值=0.038)。两组的并发症发生率无显著差异。
结论。ESD 显示出更高的完全切除率,特别是在垂直切缘,且并发症发生率相似。我们轻度推荐 ESD 而非 EMR 用于切除 I 型胃类癌肿瘤。